Primary screening of blood donors by NAT testing for HCV-RNA: Development of an "in-house" method and results

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 49, Issue 3, 2007, Pages 177-185

  Wendel, Silvano ^a,b,g   Levi, José Eduardo ^a,b   Takaoka, Deise Tihe ^b   Silva, Isabela Cristina ^b   De Castro, Juliana Polachini ^b   Torezan Filho, Mário A ^a,b   Ghaname, Jorge ^c   Gioachini, Romualdo ^d,e   Brandão, Joselito ^e   Durigon, Edison Luis ^f  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b Centro de Imunologia e Imunogenetica   (Brazil)

^c Hospital Nove de Julho   (Brazil)

^d Oswaldo Cruz Hospital   (Brazil)

^e Hospital Evaldo Foz   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g NONE   (Brazil)

Author keywords

Blood donors; HCV; Hepatitis C virus; Nucleic acid testing; RT PCR; Transfusional risk

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; GENOTYPE; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; NUCLEIC ACID ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY;

EID: 34447282783     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/s0036-46652007000300008     Document Type: Article

References (38)

1. ARROJO, I.P.; PAREJA, M.O.; ORTA, M.D.R. et al. - Detection of a healthy carrier of HCV with no evidence of antibodies for over four years. Transfusion, 43: 953-957, 2003.
2. BUSCH, M.P.; TOBLER, L.H.; GERLICH, W.H. et al. - Very low level viremia in HCV infectious unit missed by NAT. Transfusion, 43: 1173-1174, 2003.
3. CAMPIOTTO, S.; PINHO, J.R.; CARRILHO, F.J. et al. - Geographic distribution of hepatitis C virus genotypes in Brazil. Braz. J. med. biol. Res., 38: 41-49, 2005.
4. CLELAND, A.; DAVIS, C.; ADAMS, N. et al. - Development of multiplexed nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virus. Vox Sang. (Basel), 81: 93-101, 2001.
5. COSTE, J.; REESINK, H.W.; ENGELFRIET, C.P. et al. - Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang. (Basel), 88: 289-303, 2005.
6. DELWART, E.L.; KALMIN, N.D.; JONES, T.S. et al. - First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang. (Basel), 86: 171-177, 2004.
7. DOW, B.C.; MUNRO, H.; BUCHANAN, I. et al. - Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening. Vox Sang. (Basel), 86: 15-20, 2004.
8. FDA/ Center for Biologics Evaluation and Research - Use of nucleic acid tests on pooled and individual samples from donors of whole blood and blood components for transfusion to adequately and appropriately reduce the risk of transmission of HIV-1 and HCV. Guidance for Industry, Draft guidance. March 2002. Available at http://www.fda.gov/cber/gdlns/hivhcvnatbld.pdf and http://www.fda.gov/cber/gdlns/hivnas.pdf
9. GAUDY, C.; MOREAU, A.; BRUNET, S. et al. - Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection of fourth-generation immunoassay for HIV infection. J. clin. Microbiol., 42: 2847-2849, 2004.
10. GLYNN, S.A.; KLEINMAN, S.H.; WRIGHT, D.J.; BUSCH, M.P. & NHLBI RETROVIRUS EPIDEMIOLOGY DONOR STUDY - International application of the incidence rate/window period model. Transfusion, 42: 966-972, 2002.
11. GLYNN S.A.; WRIGHT, D.J.; KLEINMAN, S.H. et al. - Dynamics of viremia in early hepatitis C virus infection. Transfusion, 45: 994-1002, 2005.
12. HEWLETT, I.K. & EPSTEIN, J.S. - Food and Drug Administration Conference on the feasibility of genetic technology to close the HIV window in donor screening (conference report). Transfusion, 37: 346-351, 1997.
13. HOOFNAGLE, J.H. - Course and outcome of hepatitis C. Hepatology, 36 (suppl.1): S21-S29, 2002.
14. JAPANESE RED CROSS NAT SCREENING RESEARCH GROUP - Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. Jap. J. infect. Dis., 53: 116-123, 2000.
15. JONGERIUS, J.M.; SJERPS, M.; CUIJPERS, T.M. et al. - Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening. Transfusion, 42: 792-797, 2002.
16. KONNICK, E.Q.; ERALI, M.; ASHWOOD, E.R. & HILLYARD, D.R. - Performance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit assay and the National Genetics Institute HCV Superquant assay. J. clin. Microbiol, 40: 768-773, 2002.
17. KOTHE, D.; BYERS, R.H.; CAUDILL, S.P. et al. - Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J. Acquir. Immune Defic. Syndr., 33: 625-634, 2003.
18. LEVI, J.E.; CONTRI, D.G.; TAKAOKA, D.T. & WENDEL, S. - PCR as a tool for primary screening of blood donors. Transfusion, 38(suppl. 10): 57, 1998.
19. LEVI, J.E. - Triagem de doadores de sangue por PCR: desenvolvimento e aplicação na detecção do vírus da hepatite C. São Paulo, 2000. (Dissertação de doutorado - Instituto de Ciências Biomédicas da Universidade de São Paulo).
20. LEVI, J.E.; CONTRI, D.G.; LIMA, L.P. et al. - High prevalence of GB virus C/hepatitis G virus RNA among Brazilian blood donors. Rev. Inst. Med. trop. S. Paulo, 45: 75-78, 2003.
21. LEVI, J.E.; WENDEL, S.; TAKAOKA, D.T. et al. - Replacement of HIV p24 Ag test by a multiplex RT-PCR method for primary screening of blood donors. Rev. Inst. Med. trop. S. Paulo, 49: 171-176, 2007.
22. LING, A.E.; ROBBINS, K.E.; BROWN, T.M. et al. - Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. J. Amer. Med. Ass., 284: 210-214, 2000.
23. MAC DOWELL, B.; AMORIM, L.; SABACK, F.L.; MELO, H. & MENDES, A. - Resultados dos testes de biologia molecular (NAT) para os vírus HIV, hepatite B (HBV) e hepatite C (HCV) em doadores de sangue. In: CONGRESSO BRASILEIRO DE EPIDEMIOLOGIA, VI, Recife, 2004. Anais.
24. MINE, H.; EMURA, H.; MIYAMOTO, M. et al. - High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J. virol. Meth., 112: 145-151, 2003.
25. OPERSKALSKI, E.A.; MOSLEY, J.W.; TOBLER, L.H. et al. - HCV viral load in anti-HCV-reactive donors and infectivity for their recipients. Transfusion, 43: 1433-1441, 2003.
26. OKAMOTO, H.; OKADA, S.; SUGIYAMA, Y. et al. - Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jap. J. exp. Med., 60: 215-222, 1990.
27. PAUL-EHRLICH INSTITUTE - Requirements for the validation and routine operation of the HCV-NAT in the blood collection service. Available at http://www.pei.de/english/valid_engl.pdf
28. PEALER, L.N.; MARFIN, A.A.; PETERSEN, L.R. et al. - Transmission of West Nile virus through blood transfusion in the United States in 2002. New. Engl. J. Med., 349: 1236-1245, 2004.
29. ROTH, W.K.; WEBER, M. & SEIFRIED, E. - Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet, 353: 359-363, 1999.
30. ROTH. W.K. & SEIFRIED, E. - The German experience with NAT. Transfus. Med., 12: 255-258, 2002.
31. SALDANHA, J. & MINOR, P. - A sensitive PCR method for detecting HCV RNA in plasma pools, blood products and single donations. J. med. Virol., 43: 72-76, 1994.
32. SCHREIBER, G.B.; BUSCH, M.P.; KLEINMAN, S.H. & KORELITZ, J.J. - The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. New Engl. J. Med., 334: 1685-1690, 1996.
33. SMITH, D.B.; MELLOR, J.; JARVIS, L.M. et al. - Variation of the hepatitis C virus 5′ non-coding region: implications for secondary structure, virus detection and typing. The International HCV collaborative study group. J. gen. Virol., 76: 1749-1761, 1995.
34. STRAMER, S.L.; CAGLIOTI, S. & STRONG, D.M. - NAT of the United States and Canadian blood supply. Transfusion, 40: 1165-1168, 2000.
35. STRAMER, S.L.; GLYNN, S.A.; KLEINMAN, S.H. et al. - Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. New Engl. J. Med., 351: 760-768, 2004.
36. TOBLER, L.H.; STRAMER, S.L.; LEE, S.R. et al. - Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors. Vox Sang. (Basel), 89: 201-207, 2005.
37. WENDEL, S.; CONTRI, D.G.; TAKAOKA, D.T. et al. - Screening of blood donors for HCV-RNA: development of a PCR test and results after 20 months. Vox Sang. (Basel), 78(suppl. 1): 429, 2000.
38. XIANG, J.; WUNSCHMANN, S.; SCHMIDT, W.; SHAO, J. & STAPLETON, J.T. - Full-length GB virus C (Hepatitits G virus) RNA transcripts are infectious in primary CD4-positive T cells. J. Virol. 74: 9125-9133, 2000.